profit from every $100 of sales.
$0$100
Sabra Health Care REIT
$20.97-1.64% today
+9.4% in 1 year
1-year low $17.671-year high $22.39
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $35.30 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Sabra Health Care REIT sold, what it kept, and what it did with the cash.
Sales went from $625 million in 2022 to $775 million in 2025, with $156 million of profit last year.
SalesProfit
Sabra Health Care REIT handed back 83% of the cash it generated last year.
$289M
Free cash flow 2025$349M
Bought back its own shares–
Paid as dividends$289M
Cash vs. debt$72M vs. $2.6B
Sabra Health Care REIT vs. similar companies
Sabra Health Care REIT grows the slowest of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Sabra Health Care REIT | 35.3× · Expensive | ||
 Welltower | 193.7× · Very expensive | ||
 Ventas | 190.2× · Very expensive | ||
 Omega Healthcare Investors | 25.9× · Fair price | ||
 Healthpeak Properties | 207.4× · Very expensive |
AI analysis
An AI analyst reads Sabra Health Care REIT's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 599 | 570 | 625 | 648 | 703 | 775 | |
| – | – | 462 | 452 | 476 | 504 | |
| – | – | 235 | 222 | 256 | 264 | |
| 433 | 358 | 217 | 312 | 413 | 457 | |
| 138 | -113 | -78 | 14 | 127 | 156 | |
| 0.67 | -0.52 | -0.34 | 0.06 | 0.54 | 0.64 | |
| – | – | 74.0% | 69.8% | 67.7% | 65.0% | |
| – | – | 37.6% | 34.2% | 36.5% | 34.1% | |
| 23.1% | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 5,986 | 5,967 | 5,748 | 5,386 | 5,304 | 5,493 |
| Cash | 59 | 112 | 49 | 41 | 60 | 72 |
| Total debt | 2,372 | 2,394 | 2,549 | 2,447 | 2,444 | 2,550 |
| Total liabilities | 2,576 | 2,587 | 2,691 | 2,584 | 2,562 | 2,670 |
| 3,409 | 3,380 | 3,056 | 2,803 | 2,741 | 2,822 | |
| 207 | 219 | 231 | 233 | 236 | 244 | |
| 3.5% | 2.5% | 0.4% | 1.9% | 3.7% | 4.0% | |
| 4.1% | -3.4% | -2.5% | 0.5% | 4.6% | 5.5% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 355 | 356 | 316 | 301 | 311 | 349 | |
| – | – | – | – | – | – | |
| – | – | 316 | 301 | 311 | 349 | |
| Dividends paid | 278 | 263 | 277 | 277 | 280 | 289 |
| – | – | 5 | 3 | – | – | |
| 8 | 8 | 7 | 8 | 9 | 11 |
Valuation
- 35.3×
- 30.8×
- –
- 1.9×
- 7.1×
- 15.8×
- 17.5×
- 6.3%
- 2.8%
- 5.8%
Profitability
- 65.0%
- 34.1%
- 20.1%
- 53.9%
- 4.2%
- 0.5%
- 5.6%
- 2.8%
- 4.2%
- –
Growth
- +5.3%
- −0.9%
- +12.3%
- −2.3%
- +2.4%
Financial health
- 5.9×
- 0.97
- 48.2%
- 2.0×
- 13.85
- 13.85
- 0.15
How it ranks in Real Estate
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 45%of 746
Bottom 45%of 752
Bottom 18%of 666
Bottom 42%of 762
Top 44%of 763
What analysts expect
- Average price target
- $21.20
- Range
- $21.00 – $22.00
- 2 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 29, 2026 | 0.39 | 0.17 | +134.0% |
| Feb 12, 2026 | 0.38 | 0.17 | +123.5% |
| Nov 5, 2025 | 0.38 | 0.38 | +0.0% |
| Aug 4, 2025 | 0.38 | 0.37 | +2.7% |
| May 5, 2025 | 0.37 | 0.36 | +2.8% |
| Feb 19, 2025 | 0.36 | 0.36 | +0.0% |
| Oct 31, 2024 | 0.37 | 0.36 | +2.8% |
| Aug 7, 2024 | 0.36 | 0.35 | +2.9% |
5.8%of the share price, paid each year
On $1,000 invested$58a year at today's yield, before tax
−2.3%2020 to 2025
Raised–not every year
Paid per share, each year
$1.60 in 2015 → $1.20 in 2025
How safe it looks
186.0% of its profit
Room to growStretchedMore than it earns: 83.0%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
59No pass
Benjamin Graham
55No pass
Philip Fisher
57No pass
Peter Lynch
51No pass
Joel Greenblatt
43No pass
Charlie Munger
63Pass
Terry Smith
58No pass
Questions about Sabra Health Care REIT
Is Sabra Health Care REIT a good stock to buy?
A business with weak numbers, but the price is high. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Sabra Health Care REIT AI analysis
What does Sabra Health Care REIT do?
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. It is in REIT - Healthcare Facilities, based in Tustin, CA, United States, with 58 employees.
Does Sabra Health Care REIT pay a dividend?
Yes. At today's price the dividend is 5.8% a year, about 186% of its yearly profit. In 2025 it paid out $289 million in dividends.
Is Sabra Health Care REIT stock halal?
No. Sabra Health Care REIT does not pass our halal screen: its debt is 46% of its market value, at or above the 33% limit. How we check
How has Sabra Health Care REIT stock done over the past year?
Up 9.4% over the past twelve months, to $20.97. It traded between $17.67 and $22.39 and is 6.3% below its high.
Who are Sabra Health Care REIT's competitors?
The largest listed companies in the same industry are Welltower, Ventas, Omega Healthcare Investors and Healthpeak Properties. The peers table on this page compares their profit, growth and price with Sabra Health Care REIT's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.